| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4773127 | F | Cytotoxicity against human DU-145 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay | Homo sapiens | 36 | ALA4765407 | cell-based format | Scientific Literature | |
| 2. | ALA4773131 | F | Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay | Homo sapiens | 20 | ALA4765407 | cell-based format | Scientific Literature | |
| 3. | ALA4773132 | F | Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay | Homo sapiens | 27 | ALA4765407 | cell-based format | Scientific Literature | |
| 4. | ALA4773134 | F | Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay | Homo sapiens | 13 | ALA4765407 | cell-based format | Scientific Literature | |
| 5. | ALA4773135 | F | Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay | Homo sapiens | 19 | ALA4765407 | cell-based format | Scientific Literature | |
| 6. | ALA4773136 | F | Cytotoxicity against human PANC-1 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay | Homo sapiens | 31 | ALA4765407 | cell-based format | Scientific Literature | |
| 7. | ALA4773137 | F | Cytotoxicity against human MIA PaCa-2 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay | Homo sapiens | 25 | ALA4765407 | cell-based format | Scientific Literature | |
| 8. | ALA4773138 | F | Cytotoxicity against human BXPC-3 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay | Homo sapiens | 14 | ALA4765407 | cell-based format | Scientific Literature | |
| 9. | ALA4773139 | F | Cytotoxicity against human ASPC1 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay | Homo sapiens | 19 | ALA4765407 | cell-based format | Scientific Literature | |
| 10. | ALA4773140 | F | Cytotoxicity against human Capan-2 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay | Homo sapiens | 9 | ALA4765407 | cell-based format | Scientific Literature | |
| 11. | ALA4773150 | F | Antitumour activity against Walker 256 adenocarcinoma cells implanted in Wistar rat assessed as increase in animal survival rate by measuring T/C ratio at 2.5 mg/kg, ip qd for 3 days administered on day 3,4,5 after tumor cell transplantation | Rattus norvegicus | 6 | ALA4765407 | organism-based format | Scientific Literature | |
| 12. | ALA4773209 | F | Antitumour activity against human PANC-1 cells xenografted in Crl:Nu-Foxnl nu mouse assessed as inhibition of tumour growth at total effective dose of 16 mg/kg, iv measured on day 33 | Homo sapiens | 1 | ALA4765407 | organism-based format | Scientific Literature | |
| 13. | ALA4773210 | F | Antitumour activity against human MIA PaCa-2 cells xenografted in Crl:Nu-Foxnl nu mouse assessed as inhibition of tumour growth at total effective dose of 12 mg/kg, ip measured on day 15 | Homo sapiens | 1 | ALA4765407 | organism-based format | Scientific Literature | |
| 14. | ALA4773211 | F | Antitumour activity against human BXPC-3 cells xenografted in Crl:Nu-Foxnl nu mouse assessed as inhibition of tumour growth at total effective dose of 16 mg/kg, iv measured on day 44 | Homo sapiens | 1 | ALA4765407 | organism-based format | Scientific Literature | |
| 15. | ALA4773212 | F | Antitumour activity against human BXPC-3 cells xenografted in Crl:Nu-Foxnl nu mouse assessed as inhibition of tumour growth at total effective dose of 16 mg/kg, iv measured on day 32 | Homo sapiens | 1 | ALA4765407 | organism-based format | Scientific Literature | |
| 16. | ALA4773213 | F | Antitumour activity against human ASPC1 cells xenografted in Crl:Nu-Foxnl nu mouse assessed as inhibition of tumour growth at total effective dose of 16 mg/kg, iv measured on day 39 | Homo sapiens | 1 | ALA4765407 | organism-based format | Scientific Literature | |
| 17. | ALA4773214 | F | Antitumour activity against human DU-145 cells xenografted in Crl:Nu-Foxnl nu mouse assessed as inhibition of tumour growth at total effective dose of 16 mg/kg, iv measured on day 33 | Homo sapiens | 1 | ALA4765407 | organism-based format | Scientific Literature | |
| 18. | ALA4773215 | F | Antitumour activity against human MDA-MB-231 cells xenografted in Crl:Nu-Foxnl nu mouse assessed as inhibition of tumour growth at total effective dose of 32 mg/kg, iv measured on day 32 | Homo sapiens | 1 | ALA4765407 | organism-based format | Scientific Literature | |
| 19. | ALA4773237 | T | Toxicity in iv dosed BALB/c mouse assessed as maximum tolerated dose administered as single dose | Mus musculus | 5 | ALA4765407 | organism-based format | Scientific Literature | |
| 20. | ALA4773241 | T | Toxicity in iv dosed BALB/c mouse assessed as maximum tolerated dose administered as 6 doses at 3 times per week for 2 weeks | Mus musculus | 5 | ALA4765407 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!